



SR groups conducted with: 1) caregivers of childrenwith SED who have taken psychoactive medications,2) pediatricians who have prescribed suchmedications, and 3) case workers who have
connected their clients to professionals for
medication or medication evaluations.    
Pediatrician Interview Study
Training: All interviewed pediatricians reported
prescribing psychoactive medications to their
patients. However, almost two-thirds (64%)
reported no specialized training in psychopharmacology.
Connections with Psychiatry: On average,
59% of the pediatrition’s patients with DSM-IV
diagnoses who were not already connected with a psy-
chiatrist, were referred to one. Once seen by other
clinicians, the pediatricians reported they rarely
got even basic information (e.g. diagnosis,
medication information, recommendations) from their
colleagues. On average, they reported never
receiving information from psychiatrists 59% of
the time, while only 18% indicated that they
received helpful information most of the time.
Comfort with Psychiatric Diagnosis: Most
pediatricians indicated that they were very or
somewhat comfortable diagnosing Depression
(86%), ADHD (82%) and Eating Disorders
(82%) without specialty consultation.  However,
most indicated that they were somewhat or very
uncomfortable making diagnoses of Bipolar disorder
(91%), Post Traumatic Stress Disorder (PTSD)
(77%), Tourette's Syndrome (68%) and Autism
(65%) without specialty consultation.
Comfort with Psychopharmacological Treatment:
There was a very high level of comfort prescrib-
ing the stimulants that are typically used in
treating ADHD, a relatively high degree of com-
fort prescribing SSRIs, and a relative lack of
comfort prescribing virtually all other classes of
psychopharmacological agents. No pediatricians
interviewed reported being comfortable in treating
bipolar disorder or PTSD with medication without
In recent years there has been a markedincrease in prescriptions for psychotropicmedications written for children and
adolescents, including a 3 to 5-fold increase in
anti-depressant prescriptions, a 7-fold increase
in amphetamine prescriptions, and more than
a 2-fold increase in the prescriptions of
antidepressants to preschoolers.1, 2
Who has been writing these prescriptions for
children and adolescents? Most stimulant
medication prescriptions originate from
primary care providers.3 One study showed
that pediatricians wrote 59% of
methylphenidate prescriptions,4 and another
study found 58% of pediatricians prescribed
SSRIs to their patients, with 31% prescribing
SSRIs in combination with other psychotropic
medications.5 In Massachusetts, over 1/4
(28%) of all psychoactive medications
prescribed in 2001 to children were prescribed
by pediatricians. 
Little is known about the types of training
pediatricians have in diagnosing and treating
psychological disorders in children and
adolescents. Studies have found more than
half of children receiving stimulant medications do
not meet criteria for Attention Deficit
Hyperactivity Disorder (ADHD).6,7 This indi-
cates that pediatric stimulant prescribing is
inconsistent with current diagnostic guidelines.   
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Studies in Massachusetts
In the Commonwealth, two studies were
undertaken by researchers at the CMHSR
to further examine issues in pediatric prescrib-
ing. The first study involved in-depth
interviews with 23 pediatricians about
their training and experiences with pre-
scribing psychoactive medications. The
Opinions expressed in this brief are those of the authors and not necessarily those of UMass Medical School or CMHSR.
specialty consultation. Despite the relatively low  level of
expressed comfort prescribing many medications, most found
themselves in situations where they prescribed them on
occasion.  
Focus Groups
Caregivers. Caregivers reported lengthy times (8
months - 14 yrs) to secure appropriate treatment for their
children. A common theme was that caregivers felt their
children's pediatricians didn't really listen to their concerns
about their children. For example, one caregiver said she'd
asked her pediatrician for a testing referral for 2 ½ years
but the doctor refused. Until their children were properly
diagnosed, many felt they had spent months or years
bringing their children to treatment that was ineffective or
not as helpful as it could have been. Another recurrent
theme was that once psychological testing was initiated,
correct diagnoses led to treatment plans (including med-
ication changes) which were helpful. Caregivers also
reported a lack of continuity in care due to a high turnover
rate among clinicians, resulting in long gaps in care. 
Pediatricians. A primary theme in this group was the
great difficulty in getting referrals for psychiatric care for
their patients, usually because clinicians aren't taking new
patients, or because of insurance issues. They also noted
that some patients are reluctant to see psychiatrists, or
simply can not wait months for an appointment and would
prefer to have their pediatricians prescribe for psychiatric
issues. In the meantime, patients and caregivers get
frustrated, angry and begin "demanding medication from me."
Case Workers. Participants were concerned about the
lack of psychiatric providers, and difficulties in the
cont inuity of care for therapy and medication.
Participants also noted that pediatricians were very likely
to diagnose ADHD and prescribe stimulant medication
for their clients. They expressed concern that other
psychiatric and behavioral issues were overlooked.  
Policy Implications & Future Directions
Pediatricians report limited training and comfort with
prescribing medications for behavioral health problems,
particularly outside the realm of ADHD and stimulant
medications. As it is likely that such demands on pediatricians
will continue to increase, additional training in psy-
chopharmacological issues for children would be useful
and welcome by many pediatricians. This can take the
form of formal training and continuing education, or
through having trained psychopharmacologists as part of
pediatrics clinics for additional support.
A frustration commonly reported by physicians, care-
givers and case workers was a lack of access to child psy-
chiatric services, both for patients and for support and
consultation for pediatricians. Programs and services to
improve access are greatly needed. 
While pediatricians felt comfortable diagnosing and pre-
scribing for ADHD, caregivers and case workers thought
pediatricians are too quick to diagnose and prescribe for
ADHD and are likely to overlook other issues, such as
depression or learning disabilities. In many instances,
caregivers found their children only began to be treated
properly with medication after a thorough psychological
testing and assessment battery.  Without a clear diagnostic
picture, children are at risk of being incorrectly treated.
While this up-front expense may seem large, it can
be cost-beneficial when it prevents years of incorrect
treatment and medication.8 Increasing access to and
reimbursement for psychological and neuropsychological
testing for children with medication needs is warranted. 
In most health care arenas, it is common practice for a
specialist to send a treatment note along to the referring
physicians. Not so for pediatricians who refer to psychiatrists.
Copies of treatment notes to the referring doctors would be
very helpful for pediatricians managing medications for
their patients.  
Alignment of child psychiatric services with physician
groups is needed for pediatricians to have ready access to
referrals, and formal and informal consultations.  In many
clinics and practices, this kind of arrangement does appear
to be working well. Such an arrangement also reduces
referral waits, and promotes continuity of care.  
Visit us on-line at www.umassmed.edu/cmhsr
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